XM does not provide services to residents of the United States of America.
L
L

Lanxess

News

Diageo, Publicis, Wolters Kluwer NV

EUROPE RESEARCH ROUNDUP-Diageo, Publicis, Wolters Kluwer NV July 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Diageo, Publicis and Wolters Kluwer NV, on Thursday. HIGHLIGHTS * Diageo DGE.L : HSBC cuts target price to 3,300p from 3,500p * Mfe-Mediaforeurope NV MFEB.MI : JP Morgan raises to overweight from neutral * Prosiebensat 1 Media SE PSMGn.DE : JP Morgan raises to overweight from neutral * Publicis PUBP.PA : JP Morgan cuts
A
A
A
B
C
C
D
D
D
D
E
E
G
H
K
L
P
R
S
S
V
A
A
A
A
B
D
G
J
W

VCI Steilemann: Foreign Investments In German Chemical Industry Are Welcomed - Conf Call

BRIEF-VCI Steilemann: Foreign Investments In German Chemical Industry Are Welcomed - Conf Call July 8 (Reuters) - VCI: VCI PRESIDENT STEILEMANN: FOREIGN INVESTMENTS IN GERMAN CHEMICAL INDUSTRY ARE VERY WELCOMED - CONFERENCE CALL Further company coverage: 1COV.DE (Gdansk Newsroom)
B
L

Germany's VCI says chemical industry's half-year sales fall 1%, confirms outlook

Germany's VCI says chemical industry's half-year sales fall 1%, confirms outlook July 8 (Reuters) - Germany's chemical industry recorded sales of 112 billion euros ($121 billion) in the first half of 2024, down 1% from 114 billion euros last year, as the mood in the industry remains cautious, industry lobby VCI said on Monday. The chemicals sector, Germany's third-largest industry that employs roughly half a million workers, continues to struggle as customers are reluctant to place new orders am
B
L

Bunzl, Relx, Rolls-Royce

EUROPE RESEARCH ROUNDUP-Bunzl, Relx, Rolls-Royce July 4 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Bunzl, Relx and Rolls-Royce, on Thursday. HIGHLIGHTS * Biomerieux BIOX.PA : Midcap raises to buy from hold * Bunzl BNZL.L : HSBC raises to buy from hold * Hennes & Mauritz HMB.ST : HSBC raises to buy from hold * Relx REL.L : Citigroup raises target price to 3525p from 3300p * Rolls-Royce RR.L : Barclays raises target price to 495p
A
A
A
B
B
G
G
G
H
H
L
L
M
N
N
R
S
S
T
U
U
W
A
H
A
P
R
R
W

GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo

BUZZ-GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo ** Goldman Sachs favours consumer ingredient and gasses cos over diversified chemicals and paint makers based on pricing power, as the European chemicals sector faces an uneven recovery ** GS notes Europe's STOXX chemicals sub-index .SX4P is up 13% from its October 2023 tr
A
B
C
C
G
L
S
U
A
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.